GeneDx Holdings Corp.
WGS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,066,859 | $66,858 | $89,164 | $482,025 |
| - Cash | $85,212 | $99,681 | $137,403 | $400,569 |
| + Debt | $116,168 | $119,770 | $77,134 | $32,846 |
| Enterprise Value | $2,097,815 | $86,947 | $28,895 | $114,302 |
| Revenue | $305,450 | $202,566 | $234,694 | $212,195 |
| % Growth | 50.8% | -13.7% | 10.6% | – |
| Gross Profit | $194,397 | $90,006 | -$26,750 | -$16,602 |
| % Margin | 63.6% | 44.4% | -11.4% | -7.8% |
| EBITDA | -$1,260 | -$136,460 | -$398,198 | -$220,748 |
| % Margin | -0.4% | -67.4% | -169.7% | -104% |
| Net Income | -$52,286 | -$175,767 | -$548,980 | -$245,390 |
| % Margin | -17.1% | -86.8% | -233.9% | -115.6% |
| EPS Diluted | -1.94 | -7.23 | -53.63 | -74.93 |
| % Growth | 73.2% | 86.5% | 28.4% | – |
| Operating Cash Flow | -$28,496 | -$180,147 | -$319,155 | -$190,434 |
| Capital Expenditures | -$5,491 | -$5,711 | -$14,322 | -$20,786 |
| Free Cash Flow | -$33,987 | -$185,858 | -$333,477 | -$211,220 |